|Page (1) of 1 - 04/18/12||email article||print page|
Actress Cynthia Nixon Reveals How Rosacea Has Impacted Her LifeNew Public Service Announcement Encourages Awareness and Diagnosis of Common Skin Condition During Rosacea Awareness Month in April (April 18, 2012)
BARRINGTON, IL -- (Marketwire) -- 04/18/12 -- Award-winning actress Cynthia Nixon reveals for the first time ever that she has rosacea in a new online public service announcement in collaboration with the National Rosacea Society. The online public service announcement features Cynthia Nixon speaking openly about her experience with rosacea and encouraging people to seek diagnosis from a dermatologist to keep their rosacea from potentially worsening over time.(1A)
"It was a relief to find out from my dermatologist what was going on with my skin, especially because rosacea can get worse if it's not treated," says Cynthia Nixon, award-winning actress. "My dermatologist told me that my harsh, do-it-yourself skin care routine was actually contributing to my rosacea flare-ups, and she helped me develop a regimen that worked for me."
Rosacea is a chronic vascular condition, and it is caused by inflammation.(2A) Symptoms may include facial redness, pimples and eye irritation, and it can even lead to thickened skin and permanent visible blood vessels.(1B) Rosacea's symptoms can be unpredictable, and the National Rosacea Society cites that triggers such as sun exposure, exercise, spicy foods, alcohol and hot and cold weather can aggravate symptoms.(3) The symptoms typically emerge starting around age 30 in men and women.(1C) It can look like acne, eczema or skin allergies, making it tough to recognize.(2B)
"Over 16 million Americans have rosacea, but 78 percent of Americans have no knowledge of this condition, including how to recognize it and what to do about it," says Sam Huff, Executive Director, National Rosacea Society. "It's important to spread awareness because in addition to the physical symptoms, rosacea can cause anxiety, self-consciousness and embarrassment among sufferers."
To view Cynthia's public service announcement and to find a dermatologist by zip code, visit www.ROSACEAFACTS.com. For more information about patient resources, visit www.rosacea.org or call 1-888-NO BLUSH. The online public service announcement was created in collaboration with the National Rosacea Society and provided by Galderma Laboratories, L.P.
Rosacea is a chronic vascular disorder affecting the face. The characteristic inflammatory skin lesions (redness, visible blood vessels, papules and pustules) appear in the middle of the face (forehead, nose, cheeks) between the ages of 20 and 50, but typically are most common in men and women after 30.(1C)
Flushing due to triggers, including sun exposure, spicy food, alcohol, weather changes, sun and hot showers, often have a negative impact on the patients' social lives. Stinging, burning and sensitivity of the skin and intolerance to cosmetics are also very common, and in some cases the eyes can become red, dry and itchy. The pathogenesis of the disease is not yet fully known; however, the inflammatory response and facial vessels may play an important role, particularly in the papulopustular form of the disease. It is currently held that there is no bacterial pathogen directly related to the etiology of rosacea. Presently, there is no cure for rosacea, but topical medication, systemic therapy and laser treatments may suppress its signs and symptoms. Patients should avoid triggering factors and use sun protection and gentle skin care products. Early diagnosis and management of the disease can help limit its progression. People who suspect that they may have rosacea or those who would like to learn more about this common condition are encouraged to visit www.ROSACEAFACTS.com, which is a site dedicated to providing people with information on rosacea, including symptoms and triggers, and additional resources about the condition.
About the National Rosacea Society
The National Rosacea Society (NRS) is the world's largest organization dedicated to improving the lives of the estimated 16 million Americans who suffer from this widespread but poorly understood disorder.(1) Through education and advocacy, its mission is threefold: to raise awareness of rosacea, to provide public health information on the disorder, and to encourage and support medical research that may lead to improvements in its management, prevention and potential cure. Since 1992, the NRS has made a difference in the way rosacea patients are treated and the way this widespread disorder is perceived and understood. Information and materials are available on the society's website at www.rosacea.org or call 1-888-NO BLUSH for more information.
The RosaceaFacts website (www.ROSACEAFACTS.com) was developed to educate consumers about rosacea and inform about treatment options and serve as a resource for patients. Visit www.ROSACEAFACTS.com to learn more about rosacea, take the self-screening quiz and to connect with a dermatologist in your area. www.ROSACEAFACTS.com is sponsored by Galderma Laboratories, L.P.
Galderma is a global pharmaceutical company founded in 1981 and exclusively focused on dermatology. The company has 31 wholly-owned affiliates with a worldwide network of distributors and 4,000 employees. Galderma's extensive product portfolio is available in 70 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence. In 2011, Galderma acquired Q-Med, a Swedish medical device company specialized in aesthetics, strengthening Galderma's presence in the aesthetic and corrective market.
With approximately 19% of revenues invested each year to discover and develop new products and access innovative technologies, the company is one of the world's leading investors in dermatology research and development (R&D). Four state-of-the-art R&D centers, of which Sophia Antipolis in France is one of the largest dermatology sites in the world, and four manufacturing sites, are dedicated to providing a wide range of innovative medical solutions which meet the highest standards of safety and efficacy.
Strategic global brands include Epiduo, Oracea, Clobex, Differin, Rozex/MetroGel, Silkis/Vectical, Tri-Luma, Loceryl, Cetaphil, Metvix, Azzalure, Dysport*, Restylane and Emervel.
*Dysport is a trademark of Ipsen
1 (A-C) The National Rosacea Society. "All About Rosacea." Available at: http://www.rosacea.org/patients/allaboutrosacea.php. Accessed on March 27, 2012.
2 (A-B) The Mayo Clinic. "Rosacea" Available at: http://www.mayoclinic.com/health/rosacea/DS00308. Accessed on March 27, 2012.
3 The National Rosacea Society. "Factors That May Trigger Rosacea Flare-Ups." Available at:
http://www.rosacea.org/patients/materials/triggers.php. Accessed on March 27, 2012.
4 Crawford et al. (2004) "Rosacea: I. Etiology, pathogenesis, and subtype classification." Journal of the American Academy of Dermatology.
Embedded Video Available: http://www2.marketwire.com/mw/frame_mw?attachid=1948062
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1950727
Phone number: (212) 301-7226
E-mail: [email protected]
Barbara Palombo | Mary Erhard
National Rosacea Society
Phone number: (847) 382-8971
E-mail: [email protected]
Copyright @ Marketwire
Related Keywords: cynthia nixon, rosacea, psa, skincare, dermatologist, national rosacea society, treatment, galderma , France, Marketwire, , Disease, Aging, Cancer, Surgery, Medication, Medical, Biology, Cancer, Men, Women,